George Eldridge

Chief Financial Officer at Aerovate Therapeutics

George has 25 years of experience in biotech, serving as CFO for several biotechnology companies including Curis, Targanta, and Proteon. George’s extensive background raising capital includes private, IPO and follow-on settings, investment banking, and M&A.

Links


Org chart